Physician profile
Aaron Michael Hurd
NPI 1588829055
$7,717.24
in general payments reported to CMS, 2019-2025
38 companies · $1,792 in 2025
The $1,792 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $763 · 2020: $138 · 2021: $738 · 2022: $1,654 · 2023: $1,353 · 2024: $1,279 · 2025: $1,792.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,183 · Education: $242.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,183.44 |
| Education | $241.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $2,246.80 | 2019-2025 | Alto Abdominal Stent Graft System, Endocross Device, Torus Stent Graft System |
| Medtronic, INC. | $1,379.52 | 2021-2025 | Endurant Iis, Valiant Captivia, Concertotm |
| Inari Medical, INC. | $870.37 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| W. L. Gore & Associates, INC. | $539.36 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin |
| Janssen Pharmaceuticals, INC | $323.21 | 2019-2023 | Xarelto |
| Philips North America LLC | $231.49 | 2020-2025 | Labosys, (Az7) Lasers, (Br6) Re Entry |
| Silk Road Medical, INC. | $220.62 | 2022-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Lemaitre Vascular, INC. | $202.64 | 2019-2025 | Artegraft Vascular Graft |
| Angiodynamics, INC. | $184.45 | 2021-2024 | Auryon Laser System 100-120 Vac |
| Cardiovascular Systems INC. | $130.70 | 2020-2021 | |
| Bard Peripheral Vascular, INC. | $126.91 | 2019-2022 | |
| Penumbra, INC. | $115.83 | 2025 | Indigo System, Penumbra System |
| Biocompatibles, INC. | $112.02 | 2019 | |
| Getinge USA Sales, LLC | $98.09 | 2022-2025 | Flixene |
| Artivion, INC. | $97.39 | 2024 | Vascular, Photofix Decellularized Bovine Pericardium |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $82.94 | 2022-2024 | Artis Pheno |
| Boston Scientific Corporation | $77.76 | 2020-2025 | Enroute Transcarotid Neuroprotection System |
| Organogenesis INC. | $77.70 | 2024-2025 | Puraply Wound Matrix, Via Matrix |
| Zimmer Biomet Holdings, INC. | $72.87 | 2024 | Mymobility Platform |
| E.R. Squibb & Sons, L.L.C. | $53.66 | 2021-2025 | Eliquis |
| Medtronic Vascular, INC. | $49.73 | 2019-2020 | |
| Becton, Dickinson and Company | $48.56 | 2024 | Rotarexs 6 F X 135 Cm |
| Veryan Medical Incorporated | $47.13 | 2021 | |
| Cardiva Medical, INC. | $45.09 | 2019-2022 | |
| Allergan, INC. | $31.33 | 2019 | |
| Shockwave Medical, INC | $30.06 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Smith+Nephew, INC. | $26.66 | 2019-2022 | |
| Ge Healthcare | $24.07 | 2023 | |
| Teleflex LLC | $23.58 | 2024 | Manta |
| Biocomposites INC | $23.04 | 2021 | |
| Baxter Healthcare | $18.58 | 2025 | Floseal |
| Pfizer INC. | $18.05 | 2022 | |
| Abbott Laboratories | $17.22 | 2023 | Jeti |
| Alexion Pharmaceuticals, INC. | $15.57 | 2021 | |
| Hydrofera LLC | $15.17 | 2023 | Hydrofera Blue |
| Solventum Corporation | $14.34 | 2024 | Activ.A.C., Prevena |
| Abbvie INC. | $13.39 | 2021 | |
| Convatec INC. | $11.34 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Hurd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.